Global And Japan Competent Cells Market Size, Status And Forecast 2021-2027

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Competent Cells Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 Market by Application
1.3.1 Global Competent Cells Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Competent Cells Market Perspective (2016-2027)
2.2 Competent Cells Growth Trends by Regions
2.2.1 Competent Cells Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Competent Cells Historic Market Share by Regions (2016-2021)
2.2.3 Competent Cells Forecasted Market Size by Regions (2022-2027)
2.3 Competent Cells Industry Dynamic
2.3.1 Competent Cells Market Trends
2.3.2 Competent Cells Market Drivers
2.3.3 Competent Cells Market Challenges
2.3.4 Competent Cells Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Revenue
3.1.1 Global Top Competent Cells Players by Revenue (2016-2021)
3.1.2 Global Competent Cells Revenue Market Share by Players (2016-2021)
3.2 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Competent Cells Revenue
3.4 Global Competent Cells Market Concentration Ratio
3.4.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2020
3.5 Competent Cells Key Players Head office and Area Served
3.6 Key Players Competent Cells Product Solution and Service
3.7 Date of Enter into Competent Cells Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Competent Cells Breakdown Data by Type
4.1 Global Competent Cells Historic Market Size by Type (2016-2021)
4.2 Global Competent Cells Forecasted Market Size by Type (2022-2027)

5 Competent Cells Breakdown Data by Application
5.1 Global Competent Cells Historic Market Size by Application (2016-2021)
5.2 Global Competent Cells Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Competent Cells Market Size (2016-2027)
6.2 North America Competent Cells Market Size by Type
6.2.1 North America Competent Cells Market Size by Type (2016-2021)
6.2.2 North America Competent Cells Market Size by Type (2022-2027)
6.2.3 North America Competent Cells Market Size by Type (2016-2027)
6.3 North America Competent Cells Market Size by Application
6.3.1 North America Competent Cells Market Size by Application (2016-2021)
6.3.2 North America Competent Cells Market Size by Application (2022-2027)
6.3.3 North America Competent Cells Market Size by Application (2016-2027)
6.4 North America Competent Cells Market Size by Country
6.4.1 North America Competent Cells Market Size by Country (2016-2021)
6.4.2 North America Competent Cells Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Competent Cells Market Size (2016-2027)
7.2 Europe Competent Cells Market Size by Type
7.2.1 Europe Competent Cells Market Size by Type (2016-2021)
7.2.2 Europe Competent Cells Market Size by Type (2022-2027)
7.2.3 Europe Competent Cells Market Size by Type (2016-2027)
7.3 Europe Competent Cells Market Size by Application
7.3.1 Europe Competent Cells Market Size by Application (2016-2021)
7.3.2 Europe Competent Cells Market Size by Application (2022-2027)
7.3.3 Europe Competent Cells Market Size by Application (2016-2027)
7.4 Europe Competent Cells Market Size by Country
7.4.1 Europe Competent Cells Market Size by Country (2016-2021)
7.4.2 Europe Competent Cells Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Competent Cells Market Size (2016-2027)
8.2 Asia-Pacific Competent Cells Market Size by Type
8.2.1 Asia-Pacific Competent Cells Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Competent Cells Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Competent Cells Market Size by Type (2016-2027)
8.3 Asia-Pacific Competent Cells Market Size by Application
8.3.1 Asia-Pacific Competent Cells Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Competent Cells Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Competent Cells Market Size by Application (2016-2027)
8.4 Asia-Pacific Competent Cells Market Size by Region
8.4.1 Asia-Pacific Competent Cells Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Competent Cells Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Competent Cells Market Size (2016-2027)
9.2 Latin America Competent Cells Market Size by Type
9.2.1 Latin America Competent Cells Market Size by Type (2016-2021)
9.2.2 Latin America Competent Cells Market Size by Type (2022-2027)
9.2.3 Latin America Competent Cells Market Size by Type (2016-2027)
9.3 Latin America Competent Cells Market Size by Application
9.3.1 Latin America Competent Cells Market Size by Application (2016-2021)
9.3.2 Latin America Competent Cells Market Size by Application (2022-2027)
9.3.3 Latin America Competent Cells Market Size by Application (2016-2027)
9.4 Latin America Competent Cells Market Size by Country
9.4.1 Latin America Competent Cells Market Size by Country (2016-2021)
9.4.2 Latin America Competent Cells Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Competent Cells Market Size (2016-2027)
10.2 Middle East & Africa Competent Cells Market Size by Type
10.2.1 Middle East & Africa Competent Cells Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Competent Cells Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Competent Cells Market Size by Type (2016-2027)
10.3 Middle East & Africa Competent Cells Market Size by Application
10.3.1 Middle East & Africa Competent Cells Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Competent Cells Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Competent Cells Market Size by Application (2016-2027)
10.4 Middle East & Africa Competent Cells Market Size by Country
10.4.1 Middle East & Africa Competent Cells Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Competent Cells Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Competent Cells Introduction
11.1.4 Merck KGaA Revenue in Competent Cells Business (2016-2021)
11.1.5 Merck KGaA Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Competent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Competent Cells Introduction
11.3.4 Agilent Technologies Revenue in Competent Cells Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Competent Cells Introduction
11.4.4 Takara Bio Revenue in Competent Cells Business (2016-2021)
11.4.5 Takara Bio Recent Development
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Competent Cells Introduction
11.5.4 Promega Corporation Revenue in Competent Cells Business (2016-2021)
11.5.5 Promega Corporation Recent Development
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Competent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021)
11.6.5 Beijing TransGen Biotech Recent Development
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Competent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Competent Cells Business (2016-2021)
11.7.5 GeneScript Corporation Recent Development
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Competent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Competent Cells Business (2016-2021)
11.8.5 Yeastern Biotech Recent Development
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Competent Cells Introduction
11.9.4 New England Biolabs Revenue in Competent Cells Business (2016-2021)
11.9.5 New England Biolabs Recent Development
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Competent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2016-2021)
11.10.5 QIAGEN N.V. Recent Development
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Competent Cells Introduction
11.11.4 OriGene Technologies Revenue in Competent Cells Business (2016-2021)
11.11.5 OriGene Technologies Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Competent Cells Introduction
11.12.4 Lucigen Revenue in Competent Cells Business (2016-2021)
11.12.5 Lucigen Recent Development
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Competent Cells Introduction
11.13.4 Zymo Research Revenue in Competent Cells Business (2016-2021)
11.13.5 Zymo Research Recent Development
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Competent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021)
11.14.5 Bio-Rad Laboratories Recent Development
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Competent Cells Introduction
11.15.4 Bioline Revenue in Competent Cells Business (2016-2021)
11.15.5 Bioline Recent Development
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Competent Cells Introduction
11.16.4 Delphi Genetics Revenue in Competent Cells Business (2016-2021)
11.16.5 Delphi Genetics Recent Development
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Competent Cells Introduction
11.17.4 IBA GmBH Revenue in Competent Cells Business (2016-2021)
11.17.5 IBA GmBH Recent Development
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Competent Cells Introduction
11.18.4 Cell Applications Revenue in Competent Cells Business (2016-2021)
11.18.5 Cell Applications Recent Development
11.18 BioDynamics Laboratory
.1 BioDynamics Laboratory Company Details
.2 BioDynamics Laboratory Business Overview
.3 BioDynamics Laboratory Competent Cells Introduction
.4 BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021)
.5 BioDynamics Laboratory Recent Development
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Competent Cells Introduction
11.20.4 Scarab Genomics Revenue in Competent Cells Business (2016-2021)
11.20.5 Scarab Genomics Recent Development
11.21 GCC Biotech
11.21.1 GCC Biotech Company Details
11.21.2 GCC Biotech Business Overview
11.21.3 GCC Biotech Competent Cells Introduction
11.21.4 GCC Biotech Revenue in Competent Cells Business (2016-2021)
11.21.5 GCC Biotech Recent Development
11.22 SMOBIO Technology
11.22.1 SMOBIO Technology Company Details
11.22.2 SMOBIO Technology Business Overview
11.22.3 SMOBIO Technology Competent Cells Introduction
11.22.4 SMOBIO Technology Revenue in Competent Cells Business (2016-2021)
11.22.5 SMOBIO Technology Recent Development
11.23 Edge BioSystems
11.23.1 Edge BioSystems Company Details
11.23.2 Edge BioSystems Business Overview
11.23.3 Edge BioSystems Competent Cells Introduction
11.23.4 Edge BioSystems Revenue in Competent Cells Business (2016-2021)
11.23.5 Edge BioSystems Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Competent Cells Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemically Competent Cells
Table 3. Key Players of Electrocompetent Cells
Table 4. Global Competent Cells Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Competent Cells Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Competent Cells Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Competent Cells Market Share by Regions (2016-2021)
Table 8. Global Competent Cells Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Competent Cells Market Share by Regions (2022-2027)
Table 10. Competent Cells Market Trends
Table 11. Competent Cells Market Drivers
Table 12. Competent Cells Market Challenges
Table 13. Competent Cells Market Restraints
Table 14. Global Competent Cells Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Competent Cells Market Share by Players (2016-2021)
Table 16. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020)
Table 17. Ranking of Global Top Competent Cells Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Competent Cells Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Competent Cells Product Solution and Service
Table 21. Date of Enter into Competent Cells Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Competent Cells Revenue Market Share by Type (2016-2021)
Table 25. Global Competent Cells Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Competent Cells Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Competent Cells Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Competent Cells Revenue Market Share by Application (2016-2021)
Table 29. Global Competent Cells Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Competent Cells Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Competent Cells Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Competent Cells Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Competent Cells Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Competent Cells Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Competent Cells Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Competent Cells Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Competent Cells Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Competent Cells Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck KGaA Company Details
Table 62. Merck KGaA Business Overview
Table 63. Merck KGaA Competent Cells Product
Table 64. Merck KGaA Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 65. Merck KGaA Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Competent Cells Product
Table 69. Thermo Fisher Scientific Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Agilent Technologies Company Details
Table 72. Agilent Technologies Business Overview
Table 73. Agilent Technologies Competent Cells Product
Table 74. Agilent Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 75. Agilent Technologies Recent Development
Table 76. Takara Bio Company Details
Table 77. Takara Bio Business Overview
Table 78. Takara Bio Competent Cells Product
Table 79. Takara Bio Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 80. Takara Bio Recent Development
Table 81. Promega Corporation Company Details
Table 82. Promega Corporation Business Overview
Table 83. Promega Corporation Competent Cells Product
Table 84. Promega Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 85. Promega Corporation Recent Development
Table 86. Beijing TransGen Biotech Company Details
Table 87. Beijing TransGen Biotech Business Overview
Table 88. Beijing TransGen Biotech Competent Cells Product
Table 89. Beijing TransGen Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 90. Beijing TransGen Biotech Recent Development
Table 91. GeneScript Corporation Company Details
Table 92. GeneScript Corporation Business Overview
Table 93. GeneScript Corporation Competent Cells Product
Table 94. GeneScript Corporation Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 95. GeneScript Corporation Recent Development
Table 96. Yeastern Biotech Company Details
Table 97. Yeastern Biotech Business Overview
Table 98. Yeastern Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 99. Yeastern Biotech Recent Development
Table 100. New England Biolabs Company Details
Table 101. New England Biolabs Business Overview
Table 102. New England Biolabs Competent Cells Product
Table 103. New England Biolabs Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 104. New England Biolabs Recent Development
Table 105. QIAGEN N.V. Company Details
Table 106. QIAGEN N.V. Business Overview
Table 107. QIAGEN N.V. Competent Cells Product
Table 108. QIAGEN N.V. Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 109. QIAGEN N.V. Recent Development
Table 110. OriGene Technologies Company Details
Table 111. OriGene Technologies Business Overview
Table 112. OriGene Technologies Competent Cells Product
Table 113. OriGene Technologies Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 114. OriGene Technologies Recent Development
Table 115. Lucigen Company Details
Table 116. Lucigen Business Overview
Table 117. Lucigen Competent Cells Product
Table 118. Lucigen Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 119. Lucigen Recent Development
Table 120. Zymo Research Company Details
Table 121. Zymo Research Business Overview
Table 122. Zymo Research Competent Cells Product
Table 123. Zymo Research Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 124. Zymo Research Recent Development
Table 125. Bio-Rad Laboratories Company Details
Table 126. Bio-Rad Laboratories Business Overview
Table 127. Bio-Rad Laboratories Competent Cells Product
Table 128. Bio-Rad Laboratories Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 129. Bio-Rad Laboratories Recent Development
Table 130. Bioline Company Details
Table 131. Bioline Business Overview
Table 132. Bioline Competent Cells Product
Table 133. Bioline Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 134. Bioline Recent Development
Table 135. Delphi Genetics Company Details
Table 136. Delphi Genetics Business Overview
Table 137. Delphi Genetics Competent Cells Product
Table 138. Delphi Genetics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 139. Delphi Genetics Recent Development
Table 140. IBA GmBH Company Details
Table 141. IBA GmBH Business Overview
Table 142. IBA GmBH Competent Cells Product
Table 143. IBA GmBH Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 144. IBA GmBH Recent Development
Table 145. Cell Applications Company Details
Table 146. Cell Applications Business Overview
Table 147. Cell Applications Competent Cells Product
Table 148. Cell Applications Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 149. Cell Applications Recent Development
Table 150. BioDynamics Laboratory Company Details
Table 151. BioDynamics Laboratory Business Overview
Table 152. BioDynamics Laboratory Competent Cells Product
Table 153. BioDynamics Laboratory Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 154. BioDynamics Laboratory Recent Development
Table 155. Scarab Genomics Company Details
Table 156. Scarab Genomics Business Overview
Table 157. Scarab Genomics Competent Cells Product
Table 158. Scarab Genomics Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 159. Scarab Genomics Recent Development
Table 160. GCC Biotech Company Details
Table 161. GCC Biotech Business Overview
Table 162. GCC Biotech Competent Cells Product
Table 163. GCC Biotech Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 164. GCC Biotech Recent Development
Table 165. SMOBIO Technology Company Details
Table 166. SMOBIO Technology Business Overview
Table 167. SMOBIO Technology Competent Cells Product
Table 168. SMOBIO Technology Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 169. SMOBIO Technology Recent Development
Table 170. Edge BioSystems Company Details
Table 171. Edge BioSystems Business Overview
Table 172. Edge BioSystems Competent Cells Product
Table 173. Edge BioSystems Revenue in Competent Cells Business (2016-2021) & (US$ Million)
Table 174. Edge BioSystems Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Competent Cells Market Share by Type: 2020 VS 2027
Figure 2. Chemically Competent Cells Features
Figure 3. Electrocompetent Cells Features
Figure 4. Global Competent Cells Market Share by Application: 2020 VS 2027
Figure 5. Subcloning & Routine Cloning Case Studies
Figure 6. Phage Display Library Construction Case Studies
Figure 7. Toxic/Unstable DNA Cloning Case Studies
Figure 8. High-Throughput Cloning Case Studies
Figure 9. Protein Expression Case Studies
Figure 10. Mutagenesis Case Studies
Figure 11. Single-Stranded DNA Production Case Studies
Figure 12. Bacmid Creation Case Studies
Figure 13. Cre-Lox Recombination (PIR1/PIR2) Case Studies
Figure 14. Competent Cells Report Years Considered
Figure 15. Global Competent Cells Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Competent Cells Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Competent Cells Market Share by Regions: 2020 VS 2027
Figure 18. Global Competent Cells Market Share by Regions (2022-2027)
Figure 19. Global Competent Cells Market Share by Players in 2020
Figure 20. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2020
Figure 22. Global Competent Cells Revenue Market Share by Type (2016-2021)
Figure 23. Global Competent Cells Revenue Market Share by Type (2022-2027)
Figure 24. North America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Competent Cells Market Share by Type (2016-2027)
Figure 26. North America Competent Cells Market Share by Application (2016-2027)
Figure 27. North America Competent Cells Market Share by Country (2016-2027)
Figure 28. United States Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Competent Cells Market Share by Type (2016-2027)
Figure 32. Europe Competent Cells Market Share by Application (2016-2027)
Figure 33. Europe Competent Cells Market Share by Country (2016-2027)
Figure 34. Germany Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Competent Cells Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Competent Cells Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Competent Cells Market Share by Region (2016-2027)
Figure 44. China Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Competent Cells Market Share by Type (2016-2027)
Figure 52. Latin America Competent Cells Market Share by Application (2016-2027)
Figure 53. Latin America Competent Cells Market Share by Country (2016-2027)
Figure 54. Mexico Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Competent Cells Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Competent Cells Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Competent Cells Market Share by Country (2016-2027)
Figure 60. Turkey Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Competent Cells Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Merck KGaA Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 65. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 66. Takara Bio Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 67. Promega Corporation Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 68. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 69. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 70. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 71. New England Biolabs Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 72. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 73. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 74. Lucigen Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 75. Zymo Research Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 77. Bioline Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 78. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 79. IBA GmBH Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 80. Cell Applications Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 81. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 82. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 83. GCC Biotech Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 84. SMOBIO Technology Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 85. Edge BioSystems Revenue Growth Rate in Competent Cells Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.